Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: Dr. Christopher Missling CEO Anavex Discussing current state of research into neurodegenerative disorders, such as Alzheimer's disease and Parkinson’s, and Anavex’s approach with ANAVEX 2-73. Caroline Hyde of Bloomberg Television also participates in the conversation.

Trump Says Talks Are Iran’s ‘Last Chance’ After Threats
42:36

Eight Bosses Share the Biggest Money Regrets in Their Careers
08:43

Bloomberg Businessweek Weekend: July 31st 2026
38:26